Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-027835
Filing Date
2025-03-25
Accepted
2025-03-25 17:24:21
Documents
22
Period of Report
2025-05-07

Document Format Files

Seq Description Document Type Size
1 FORM-PRE 14A tm252410-2_pre14a.htm   iXBRL PRE 14A 1260721
6 GRAPHIC bc_paidvsnetincome-4c.jpg GRAPHIC 71340
7 GRAPHIC bc_paidvstotalshare-4c.jpg GRAPHIC 73556
8 GRAPHIC lg_assertio-4c.jpg GRAPHIC 10824
9 GRAPHIC px_2025proxy01pg1-4c.jpg GRAPHIC 320242
10 GRAPHIC px_2025proxy01pg2-4c.jpg GRAPHIC 356438
  Complete submission text file 0001104659-25-027835.txt   4371769

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA asrt-20241231.xsd EX-101.SCH 10046
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asrt-20241231_def.xml EX-101.DEF 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20241231_lab.xml EX-101.LAB 35425
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20241231_pre.xml EX-101.PRE 6868
24 EXTRACTED XBRL INSTANCE DOCUMENT tm252410-2_pre14a_htm.xml XML 214232
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39294 | Film No.: 25769402
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)